October 1, 2024
ACHP calls on Congress to create a national risk pool for cutting-edge cell and gene therapies to mitigate high costs and ensure the right patients have access at a manageable cost.
New from ACHP:
- ACHP Celebrates Two Health Equity Leaders with Annual Award
- Inadequate State Payment Rates Put Medicaid Beneficiaries at Risk
- A Lifeline for Rare Diseases
- PBM Transparency, Enhanced Premium Tax Credits in ACHP’s Year-End Priorities for Congress
- Chronic Disease Pledge Bright Spot: UPMC Health Plan Prescription for Wellness
- Protect Affordable Coverage and Care
